ArcherDX, Inc.

ArcherDX, Inc.

ArcherDX, Inc.

ArcherDX, Inc., creates catalog and custom nextgeneration sequencing (NGS) assays that are purposebuilt to identify mutations and gene fusions from clinical sample types.
Founded
2013
Raised
$150M
Follow us
Alexa global traffic share
Twitter followers
15 May 2019
$60,000,000
Venture capital (Series B)
Boulder Ventures, Perceptive Advisors, The Peierls Foundation, +2
20 Mar 2018
$35,000,000
Venture capital (Series A)

ArcherDX Closes $35M Series A Financing

FinSMEs
+2